Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
CSL Ltd
CSLCurrent price
303.99 AUD
+1.89 AUD (+0.62%)
Last closed
303.1 AUD
Company
www.csl.com.au
ISIN
AU000000CSL8
Sector
Healthcare
Industry
Biotechnology
Exchange
Australian Securities Exchange
Capitalization
146 963 365 888 AUD
Yield for 12 month
+12.24 %
1Y
3Y
5Y
10Y
15Y
CSL
CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment offers plasma products, gene therapies, and recombinants. The CSL Seqirus segment provides influenza related products and pandemic services to governments. The CSL Vifor segment offers products in the therapeutic areas of iron deficiency and nephrology. The company also licenses CSL intellectual property. CSL Limited was founded in 1916 and is headquartered in Melbourne, Australia. Address: 655 Elizabeth Street, Melbourne, VIC, Australia, 3000
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
490.78 AUDP/E ratio
37.3879Dividend Yield
1.32 %Current Year
+33 614 671 780 AUD
Last Year
+29 367 645 461 AUD
Current Quarter
+15 207 721 737 AUD
Last Quarter
+18 419 675 871 AUD
Current Year
+16 363 411 702 AUD
Last Year
+14 193 395 981 AUD
Current Quarter
+6 926 063 533 AUD
Last Quarter
+9 447 696 508 AUD
Key Figures CSL
1 year
3 years
5 years
10 years
EBITDA
4 617 999 872 AUD
Operating Margin TTM
PE Ratio
37.3879
Return On Assets TTM
6.56 %
PEG Ratio
–
Return On Equity TTM
14.58 %
Wall Street Target Price
490.78 AUD
Revenue TTM
14 800 000 000 AUD
Book Value
35.93 AUD
Revenue Per Share TTM
Dividend Share
2.64 AUD
Quarterly Revenue Growth YOY
10.1 %
Dividend Yield
1.32 %
Gross Profit TTM
6 844 000 000 AUD
Earnings per share
8.12 AUD
Diluted Eps TTM
8.12 AUD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
30.7 %
Profit Margin
17.85 %
Dividend Analytics CSL
Dividend growth over 5 years
59 %Continuous growth
2 yearsPayout Ratio 5 years average
59 %Dividend History CSL
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
4
Ex Dividend Date
09.09.2024
Forward Annual Dividend Yield
1.32 %
Last Split Factor
3:1
Payout Ratio
45.18 %
Last Split Date
18.10.2007
Dividend Date
–
Stock Valuation CSL
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
37.3879
Forward PE
35.7143
Enterprise Value Revenue
7.4186
Price Sales TTM
9.93
Enterprise Value EBITDA
23.0254
Price Book MRQ
5.6703
Financials CSL
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators CSL
For 52 weeks
227.21 AUD
313.55 AUD
50 Day MA
304.91 AUD
Shares Short Prior Month
–
200 Day MA
288.84 AUD
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart